Understanding the benefits of holistic care in T2D
Seminar
•
AstraZeneca
About the CPD course
A thorough presentation developed for UK-based diabetes specialist nurses: to help HCPs look beyond sugar management: through understanding the holistic cardiovascular: renal and metabolic impact of their patients' type 2 diabetes: and provide clear information on what they should be looking out for beyond HbA1c. This presentation focuses on the burden of cardiorenal disease and type 2 diabetes: the importance of early treatment: and the use of SGLT2 inhibitors as first-line treatment for patients with type 2 diabetes: heart failure: and chronic kidney disease as recommended by NICE in the NG28 guideline.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
